TP53 and breast cancer: While the focus of prognostic and diagnostic assays had revolved around cathepsin D and p53, Sun et al. (2016) evaluated the use of cathepsin D along with cathepsins-B, -G, -K, -L, and -V in 188 BC tissue samples using IHC staining [147].